Inhibition of tissue factor by low-density lipoproteins

被引:0
作者
Elena Scoccia, Adriana [1 ]
Silvina Molinuevo, Maria [1 ]
机构
[1] Natl Univ La Plata, Fac Ciencias Exactas, Catedra Bioquim Patol, RA-1900 La Plata, Prov De Bs As, Argentina
来源
ACTA BIOQUIMICA CLINICA LATINOAMERICANA | 2006年 / 40卷 / 01期
关键词
tissue factor; thromboplastine; factor III; low density lipoproteins; pro-coagulant activity inhibition; diabetes;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Low-density lipoproteins (LDL) are circulating inhibitors of the pro-coagulant activity of tissue factor. The objective of the present work was to explore the electrophoretic mobility of the involved proteins and the kinetic of pro - coagulant activity inhibition, that allow us to propose a quantitative in vitro assay of potential clinical use. For the kinetic assay, commercial calcic thromboplastine was incubated with increasing volumes of redisolved selectively precipitated LDL at 37 degrees C. Then the prothrombine time in one step was made; the inhibitory activity and percentage of inhibition against a blank were calculated. The results show an increasing inhibition of procoagulant activity until 60 min between 0.013 - 0.026 nmol apoB. The conditions for the assay of 30 samples of normolipemic individuals (ages between 30 - 70 years old) were selected on the basis of these results. The assay of % coagulation inhibition / nmol apoB showed signficative differences for control group versus diabetic one. The protein electrophoresis showed two bands in pre-beta and beta positions corresponding to thromboplastine and LDL respectively at time zero. After 60 min of incubation one intense band corresponding to LDL - tissue factor complex can be observed. This work proposes a simple assay for the evaluation of LDL role in haemostatic control in pathological conditions, although further clinical assays are still required.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 21 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]  
BROZE GJ, 1995, THROMB HAEMOSTASIS, V74, P90
[3]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[4]  
DEMACKER PN, 1984, CLIN CHEM, V30, P1797
[5]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[6]   THE EFFECT OF LIPID-PEROXIDATION AND LIPOLYSIS ON THE ABILITY OF LIPOPROTEINS TO INFLUENCE THROMBOPLASTIN ACTIVITY [J].
ETTELAIE, C ;
HOWELL, RM ;
BRUCKDORFER, KR .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1257 (01) :25-30
[7]   THE INHIBITION OF THROMBOPLASTIN BY APOLIPOPROTEIN-B AND THE EFFECT OF VARIOUS ASSOCIATED LIPIDS [J].
ETTELAIE, C ;
HOWELL, RM .
THROMBOSIS RESEARCH, 1992, 68 (02) :175-184
[8]   Identification of a domain in apolipoprotein B-100 that inhibits the procoagulant activity of tissue factor [J].
Ettelaie, C ;
James, NJ ;
Adam, JM ;
Nicola, KP ;
Wilbourn, BR ;
Bruckdorfer, KR .
BIOCHEMICAL JOURNAL, 1998, 333 :433-438
[9]   The mechanism of inhibition of factor III (thromboplastin) activity by apolipoprotein B-100 - Protein-protein interactions [J].
Ettelaie, C ;
James, NJ ;
Wilbourn, B ;
Adam, JM ;
Naseem, KM ;
Bruckdorfer, KR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (05) :639-647
[10]   Comparison of the inhibitory effects of ApoB100 and tissue factor pathway inhibitor on tissue factor and the influence of lipoprotein oxidation [J].
Ettelaie, C ;
Wilbourn, BR ;
Adam, JM ;
James, NJ ;
Bruckdorfer, KR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (07) :1784-1790